Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/8491
Title: Angiogenesis in neurological disorders: A review
Authors: Acar, Göksemin
Tanriöver, G.
Demir, R.
Keywords: Angiogenesis
Anti-angiogenic therapies
Neurological disorders
Tumor metastasis
angiogenesis inhibitor
angiotensin II
bevacizumab
camptothecin
cediranib
cyclophosphamide
erlotinib
gefitinib
gelatinase A
gelatinase B
imatinib
lomustine
nevaxar
scatter factor
sorafenib
thrombospondin 1
unclassified drug
vasculotropin
vatalanib
angiogenesis
antiangiogenic activity
arteriovenous malformation
blood brain barrier
brain blood vessel
brain disease
brain metastasis
cancer chemotherapy
cancer growth
cancer prognosis
cell proliferation
competitive inhibition
down regulation
drug efficacy
glioblastoma
hemangioblastoma
hereditary hemorrhagic telengiectasia
histopathology
human
hypertension
hypoxemia
macrophage
maximum tolerated dose
meningioma
neurologic disease
overall survival
progression free survival
protein expression
protein secretion
review
signal transduction
thrombocytopenia
tumor cell
tumor localization
tumor vascularization
upregulation
vascular tumor
Angiogenesis Inhibitors
Animals
Brain Neoplasms
Humans
Neovascularization, Pathologic
Nervous System Diseases
Abstract: Angiogenesis, recruitment of new blood vessels, is an essential component of the metastatic pathway. These vessels provide the principal route by which tumor cells exit the primary tumor site and enter the circulation. For many tumors, the vascular density can provide a prognostic indicator of metastatic potential, with the highly vascular primary tumors having a higher incidence of metastasis than poorly vascular tumors. The discovery and characterization of tumor-derived angiogenesis modulators greatly contributed to our understanding of how tumors regulate angiogenesis. However, although angiogenesis appears to be a rate-limiting event in tumor growth and metastatic dissemination, a direct connection between the induction of angiogenesis and the progression to tumor malignancy is less well understood. In this review, we discuss the observations concerning the modulation of angiogenesis and their implications in various neurological disorders, as well as their potential impact on cancer therapy. © W. S. Maney & Son Ltd 2012.
URI: https://hdl.handle.net/11499/8491
https://doi.org/10.1179/1743132812Y.0000000068
ISSN: 0161-6412
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Show full item record



CORE Recommender

SCOPUSTM   
Citations

3
checked on Jun 29, 2024

WEB OF SCIENCETM
Citations

3
checked on Jul 17, 2024

Page view(s)

22
checked on May 27, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.